Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$105.90
0.0%
$112.52
$89.67
$121.64
$183.76B0.765.32 million shs3.61 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$149.27
-0.4%
$154.19
$143.13
$175.97
$359.25B0.558.67 million shs6.53 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.04%-1.52%-4.88%-5.56%-5.26%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.44%+2.15%-3.24%-4.69%-8.35%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9959 of 5 stars
3.35.04.24.53.22.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9046 of 5 stars
3.23.04.23.93.02.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5014.73% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8617.81% Upside

Current Analyst Ratings

Latest JNJ and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/4/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$120.00 ➝ $125.00
4/3/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$126.00 ➝ $128.00
3/13/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.58$6.36 per share16.65$22.36 per share4.74
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.22$13.61 per share10.97$29.09 per share5.13

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2132.9920.682.5513.96%20.32%10.59%7/18/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.3113.662.4745.26%36.70%15.07%7/18/2024 (Estimated)

Latest JNJ and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.08%+12.31%68.54%53 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.19%+5.70%29.68%63 Years

Latest JNJ and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable

JNJ and ABT Headlines

SourceHeadline
Adell Harriman & Carpenter Inc. Sells 7,162 Shares of Johnson & Johnson (NYSE:JNJ)Adell Harriman & Carpenter Inc. Sells 7,162 Shares of Johnson & Johnson (NYSE:JNJ)
marketbeat.com - May 4 at 6:36 AM
Shareholders in Johnson & Johnson (NYSE:JNJ) are in the red if they invested three years agoShareholders in Johnson & Johnson (NYSE:JNJ) are in the red if they invested three years ago
finance.yahoo.com - May 3 at 10:10 PM
Johnson & Johnson (NYSE:JNJ)  Shares Down 1% Johnson & Johnson (NYSE:JNJ) Shares Down 1%
marketbeat.com - May 3 at 9:54 PM
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should KnowJohnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
zacks.com - May 3 at 10:01 AM
3 Dividend Growth Stocks that Just Raised Their Payouts3 Dividend Growth Stocks that Just Raised Their Payouts
fool.com - May 3 at 8:30 AM
Retirement Systems of Alabama Trims Holdings in Johnson & Johnson (NYSE:JNJ)Retirement Systems of Alabama Trims Holdings in Johnson & Johnson (NYSE:JNJ)
marketbeat.com - May 3 at 5:51 AM
Johnson & Johnson Proposes $6.5 Billion in New Talc Settlement OfferJohnson & Johnson Proposes $6.5 Billion in New Talc Settlement Offer
nytimes.com - May 3 at 3:18 AM
Johnson & Johnson offers $6.5 billion settlement in baby powder cancer lawsuitsJohnson & Johnson offers $6.5 billion settlement in baby powder cancer lawsuits
yahoo.com - May 2 at 10:18 PM
Johnson & Johnson (NYSE:JNJ) Shares Sold by Hunter Perkins Capital Management LLCJohnson & Johnson (NYSE:JNJ) Shares Sold by Hunter Perkins Capital Management LLC
marketbeat.com - May 2 at 9:21 PM
Johnson & Johnson (NYSE:JNJ) Trading Down 0.6%Johnson & Johnson (NYSE:JNJ) Trading Down 0.6%
marketbeat.com - May 2 at 2:47 PM
Hold Rating on Johnson & Johnson Amid Ongoing Talc Litigation Uncertainties and Settlement EffortsHold Rating on Johnson & Johnson Amid Ongoing Talc Litigation Uncertainties and Settlement Efforts
markets.businessinsider.com - May 2 at 12:12 PM
Johnson & Johnson’s Strategic Settlement Plan for Ovarian Cancer Talc Claims: Financial Implications and OutlookJohnson & Johnson’s Strategic Settlement Plan for Ovarian Cancer Talc Claims: Financial Implications and Outlook
markets.businessinsider.com - May 2 at 12:12 PM
Janssen-Cilag seeks expanded EMA approval for TREMFYAJanssen-Cilag seeks expanded EMA approval for TREMFYA
pharmaceutical-technology.com - May 2 at 12:12 PM
Mastering Stocks in the Dow: Insights into the DJIA (JNJ)Mastering Stocks in the Dow: Insights into the DJIA (JNJ)
marketbeat.com - May 2 at 11:32 AM
Decoding Johnson & Johnson (JNJ): A Strategic SWOT InsightDecoding Johnson & Johnson (JNJ): A Strategic SWOT Insight
finance.yahoo.com - May 2 at 7:10 AM
The top pharmaceutical companies by R&D expenditureThe top pharmaceutical companies by R&D expenditure
pharmaceutical-technology.com - May 2 at 7:10 AM
Raymond James Financial Services Advisors Inc. Acquires 88,849 Shares of Johnson & Johnson (NYSE:JNJ)Raymond James Financial Services Advisors Inc. Acquires 88,849 Shares of Johnson & Johnson (NYSE:JNJ)
marketbeat.com - May 1 at 11:06 PM
Johnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuitsJohnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits
finance.yahoo.com - May 1 at 6:01 PM
US STOCKS-S&P 500, Nasdaq end lower after Fed rate decision, Powell press conferenceUS STOCKS-S&P 500, Nasdaq end lower after Fed rate decision, Powell press conference
finance.yahoo.com - May 1 at 6:01 PM
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices PlungeStock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
investorplace.com - May 1 at 3:57 PM
Johnson & Johnson (NYSE:JNJ) Shares Up 4.4%Johnson & Johnson (NYSE:JNJ) Shares Up 4.4%
marketbeat.com - May 1 at 1:59 PM
Janssen adopts J&J name as part of global rebranding effortJanssen adopts J&J name as part of global rebranding effort
pharmaceutical-technology.com - May 1 at 1:00 PM
JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer LawsuitsJNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits
investorplace.com - May 1 at 11:26 AM
Johnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in USJohnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in US
foxbusiness.com - May 1 at 10:15 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.